Patent ID: 9549961
Date: 2017-01-24
CPC Classifications: A61K,A61P

Claim:
1. A method for prevention or treatment of liver toxicity comprising the steps of selecting a patient in need of prevention or treatment of liver toxicity, and administering a composition comprising lactic acid bacteria fermented Galgeuntang as an active ingredient to the patient, wherein the dose of the lactic acid bacteria fermented Galgeuntang is 15-40 ml per 1 kg/day for an adult, and wherein the composition reduces the activities of one or more enzymes selected from AST (aspartate aminotransferase), ALT (alanine aminotransferase), and LDH (lactate dehydrogenase), and the administration of the composition alleviates centrilobular necrosis, vacuolar degeneration, and inflammatory cell infiltration, wherein the Galgeuntang is prepared by hot water extraction of the mixture of medicinal herbs including 2-10 parts by weight of mahuang, 2-10 parts by weight of ginger, 2-10 parts by weight of jujube, 1-7 parts by weight of licorice, 1-7 parts by weight of peony, and 1-7 parts by weight of gyeji ( wherein the lactic acid bacteria are